Besides the well‐recognized risk factors, novel conditions increasing cardiovascular
morbidity and mortality are emerging. Undesirable emotions and behavior such as anxiety …

We reappraise the psychiatric potential of calcium channel blockers (CCBs). First, voltage-
gated calcium channels are risk genes for several disorders. Second, use of CCBs is …

Abstract About 20–30% of patients with major depressive disorder (MDD) develop treatment-
resistant depression (TRD) and finding new effective treatments for TRD has been a …

Beyond blood pressure control, angiotensin receptor blockers reduce common injury
mechanisms, decreasing excessive inflammation and protecting endothelial and …

Background Angiotensin-converting enzyme inhibitors (ACEIs) are widely prescribed
antihypertensive agents. Intriguingly, case reports and clinical trials have indicated that …

Objectives To assess whether a history of major depressive disorder (MDD) in middle-aged
individuals with hypertension influences first-onset cardiovascular disease outcomes …

Background: Antihypertensive drugs, especially calcium channel blockers, have been
associated with differential rates of a number of neuropsychiatric outcomes. Delirium is …

Cardiovascular drugs impact many pathways involved in depression pathophysiology and
treatment. However, their distinct impact on mood is underrecognized and the literature is …

Objective: It is unclear whether blockade of the angiotensin system has effects on mental
health. Our objective was to determine the impact of angiotensin converting enzyme …

Emotional disorders like anxiety and depression are responsible for considerable morbidity
and mortality all over the world. Several antidepressant and anxiolytic medications are …